MHTX Stock UPDATES Manhattan Scients (MHTX) 0.1346 08/11/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Manhattan Scients (MHTX) 0.1346 $MHTX

Manhattan Scientifics Analyst Report; Potentially Disruptive Emerging Technology Play - Monetizing Intellectual Property is the Goal by BrokerBank Securities, Inc.
PR Newswire - Tue Jul 01, 7:30PM CDT
Manhattan Scientifics, Inc. (OTCQB: MHTX) MHTX is an emerging technology incubator/venture firm focused on technology transfer and commercialization of disruptive technologies in the nanomedicine space. The company is presently developing commercial medical prosthetics applications for its ultrafine grain metals and plans to commercialize the cancer research work and nanomedical applications developed by Senior Scientific LLC, a unit of the Company.

SeeThruEquity Issues Company Note on Manhattan Scientifics
ACCESSWIRE - Thu Jun 26, 8:02AM CDT
Company Announces Delivery of MRX II Cancer Detection Instrument to MD Anderson

Pushing the Limits of Cancer Detection
Business Wire - Tue Jun 10, 8:01AM CDT
--Technology Intended to Find Cancers Years Earlier

SeeThruEquity Issues Quarterly Update on Manhattan Scientifics, Highlighting Expected Shipment of MRX II Instrument to MD Anderson
ACCESSWIRE - Mon Jun 09, 1:43PM CDT
Manhattan Scientific expected to ship its MRX II cancer screening instrument to MD Anderson and Announcement of collaboration with Azano Biotech highlight developments in Q1 2014

Manhattan Scientifics Announces Commercial Introduction Of NanoMRX Precision Nanoparticles
Business Wire - Tue Mar 18, 10:45AM CDT
Manhattan Scientifics (OTCQB: MHTX) announced today a collaboration with Azano Biotech that will make NanoMRX Precision Nanoparticles available for purchase.

Manhattan Scientifics (MHTX) Announces Collaboration with MD Anderson Cancer Center to Validate New Instrument for Very Early Detection of Cancer
Business Wire - Mon Jan 27, 10:38AM CST
Manhattan Scientifics (OTC: MHTX) executed an agreement to collaborate with The University of Texas MD Anderson Cancer Center (MDACC) to advance, demonstrate and validate a breakthrough technology developed by Edward R. Flynn, PhD, for the very early detection of cancer. Dr. Flynn is the founder and chief scientist of MHTX's subsidiary, Senior Scientific LLC. Senior Scientific is seeking to commercialize this patented non-invasive technology using ultra-sensitive magnetic detectors to locate, identify and measure tumors thousands of times smaller than detectable using current technologies.

Manhattan Scientifics engages Loraine Upham to market diagnostic technology
M2 - Mon Aug 26, 5:05AM CDT
Manhattan Scientifics (OTC: MHTX) said that Loraine Upham has been engaged as a consultant to support its cancer team.

Manhattan Scientifics Announces the Engagement of Loraine Upham to Market Its Cancer Diagnostic Technology
Business Wire - Fri Aug 23, 8:00AM CDT
Manhattan Scientifics (OTCQB:MHTX) announced today that Loraine Upham has been engaged as a consultant to support its cancer team. The technology, developed by Edward R. Flynn, PhD, provides the most specific and most sensitive method for detecting cancer currently known. Ms. Upham's role will be to identify initial markets and facilitate relationships with strategic partners for the company.

OTC Daily Alert Stock Watch - Manhattan Scientifics Inc (OTCQB: MHTX)
WorldStockWire - Tue Aug 13, 8:00PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com

Senior Scientific Announces Issuance of U.S. Patent for the Detection, Measurement and Imaging of Cancer Cells Using Nanoparticles
Business Wire - Thu May 23, 8:47AM CDT
Senior Scientific, LLC, a unit of Manhattan Scientifics (OTCQB: MHTX) and a developer of molecular imaging and nanobiotechnology for the early detection and localization of cancer and other human diseases, today announced that the United States Patent Office (USPTO) has issued U.S. Patent No. 8,447,379 entitled "Detection, measurement, and imaging of cells such as cancer and other biologic substances using targeted nanoparticles and magnetic properties thereof."

Manhattan Scientifics Announces Receipt of $2.5M Commitment to Build Breakthrough Cancer Detection Devices Initial $1M Received
Business Wire - Tue Apr 09, 9:46AM CDT
Manhattan Scientifics (MHTX: OTCQB) announced today that it has received the initial $1 million of a $2.5 million commitment to build the first generation of its advanced cancer detection devices. More information can be found in the company's recent 8-K filing.

Cancer Research Breakthrough: The National Foundation for Cancer Research (NFCR) Cites Manhattan Scientifics' Early Cancer Detection Technology as "Research Breakthrough" for 2012
Business Wire - Mon Jan 07, 7:00AM CST
The National Foundation for Cancer Research (NFCR) has listed the SQUID-based cancer imaging technology developed by MHTX's (OTCBB: MHTX) Senior Scientific subsidiary as a "2012 Research Breakthrough." http://nfcr.org/research/research-accomplishments. The technology was developed by Edward R. Flynn, PhD, Senior Scientific's founder and chief scientist, in collaboration with Richard S. Larson, MD, PhD, Executive Vice Chancellor UNM Health Sciences Center in New Mexico.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

BioVersys AlpE Data Offers a Measured TB Treatment Signal

Updated Category News Views 0

Tuberculosis drug development rarely hands anybody a clean victory lap, and BioVersys' latest readout is no exception. The completed 14-day Phase 2a ENABLE study gives alpibectir plus ethionamide, known as AlpE, a credible early clinical signal in newly diagnosed drug-sensitive pulmonary TB. That matters. It does not, however, settle the far larger question of whether...

Continue Reading
&honey's U.S. Beauty Awards Sweep Puts Distribution in Focus

Updated Category News Views 128

Three glossy-magazine nods may sound fluffy, but shelf momentum is never entirely fluff. Japanese haircare brand &honey says its Deep Moist Shampoo, Treatment and Hair Oil each landed 2026 recognition from Marie Claire, ELLE and Allure. For a consumer brand trying to make an American habit out of a Japanese haircare ritual, that is the sort of validation worth...

Continue Reading
Jeff Stern Turns Travel Photography Into Full Attention

Updated Category News Views 57

A cancelled photography conference in March 2020 sent Jeff Stern toward the American Southwest, and that detour eventually became A Change of Scenery. Frankly, that origin has more grit than the usual polished creative-origin tale. While much of the world had stopped moving, Stern went alone, stood at White Pocket beneath a cobalt sky, and began reconsidering what he...

Continue Reading
Movement Elevates a Longtime Insider as Its New CEO

Updated Category News Views 81

Chalk dust rarely makes headlines, yet this is the sort of leadership change that can decide whether a consumer brand keeps its footing. Movement Climbing, Yoga and Fitness named Ryan Sewell chief executive officer effective November 18, 2026, with Anne-Worley Moelter moving into the chairperson role. It is a conspicuously internal handoff: Sewell started at the Boulder...

Continue Reading
RUDSAK Tests Premium Demand From Toronto to New York

Updated Category News Views 158

A coat rack on Bloor Street can tell a harsher story than a glossy expansion announcement. RUDSAK has opened a Toronto flagship at 55 Bloor Street West in the Manulife Centre and is preparing a boutique at American Dream outside New York City. This is a real step up in retail ambition for the Montréal luxury outerwear house, founded in 1994, and it deserves more than the...

Continue Reading
Yunnan Tin’s AI Materials Push Has Real Operating Teeth

Updated Category News Views 66

Tin rarely gets the spotlight until the machinery behind modern computing starts demanding more of it. Yunnan Tin Group is making the sensible case that this unglamorous metal can matter a great deal in semiconductors, artificial intelligence infrastructure and new-energy hardware. There is plenty of corporate ambition wrapped around that case, naturally, but a few...

Continue Reading
Baker Tilly Breach Raises Hard Questions on Vendor Risk

Updated Category News Views 30

A Quiet Vendor Failure Can Become a Loud Problem Tax files are not ordinary customer records, and that is why this reported Baker Tilly Advisory Group breach deserves more than the usual shrug people give cyber incidents. Names and addresses are bad enough; the potential exposure of Social Security numbers and other sensitive information turns a systems failure into a...

Continue Reading
Ajman Forum Puts Trust at the Center of Crisis Media

Updated Category News Views 82

Rumours do not wait politely for a communications team to finish its meeting. That plain reality sat underneath Abdulla bin Mohammed bin Butti Al Hamed's keynote at Ajman Media Forum 2026, and it is a tougher point than the usual talk about reach, engagement, or flashy new technology. In a crisis, an information vacuum gets filled fast, usually by somebody with no...

Continue Reading
NKT’s Q3 Margin Holds Up as Capacity Spending Bites

Updated Category News Views 119

Steel, copper and giant cable drums do not make for a pretty quarterly story, but NKT’s numbers have a sturdier backbone than the headline revenue dip suggests. The company delivered EUR 111 million of operational EBITDA in Q3 2026, down from EUR 119 million a year earlier, while its margin at standard metal prices edged up to 16.6% from 16.4%. That is not fireworks. It...

Continue Reading
Caliway's China Clearance Speeds CBL-514's Next Test

Updated Category News Views 18

China's regulator moved faster than the calendar, and that is the one detail worth circling in red ink. Caliway Biopharmaceuticals has received authorization from the Center for Drug Evaluation under China's National Medical Products Administration to begin CBL-0102, its China study of injectable fat-reduction candidate CBL-514. For a clinical-stage company, an...

Continue Reading

Top 5 Most Recently Viewed Articles

Immutable Expands Web3 Gaming Influence in Major Conference

Updated Category News Views 257

Immutable's Growing Presence at GDC 2025 Immutable is affirmatively stepping into the spotlight at the upcoming Game Developers Conference (GDC) 2025, a pivotal event that congregates the brightest minds of the gaming industry. With collaborations alongside notable partners such as RavenQuest, Polygon Labs, Sequence, and MetaGravity, Immutable is ready to showcase its...

Continue Reading
Rathbones Group's Influence on Empiric Student Property Plc

Updated Category News Views 239

Understanding Public Opening Position Disclosures Public opening position disclosures are essential for maintaining transparency in financial markets. This process is especially important for stakeholders interested in relevant securities, particularly when holdings exceed 1%. Disclosures must provide critical information on who owns shares and any short positions related...

Continue Reading
Rapid Nexus Achieves Historic Milestone in Wound Care Technology

Updated Category News Views 389

Rapid Nexus Receives FDA Clearance for Hemastyl Gel The FDA 510(k) clearance for its Hemastyl gel device marks the first technology that has treated the tissue surrounding chronic wounds and prevented numerous amputations. On a significant day in the realm of wound care, Rapid Nexus, a pioneering California-based med-tech company, has announced the receipt of FDA 510(k)...

Continue Reading
Grainger Approves Substantial Dividend to Shareholders

Updated Category News Views 131

Grainger's Commitment to Shareholders Through Dividends W.W. Grainger, Inc. (NYSE: GWW) has recently taken significant steps to reward its investors. The board of directors has officially approved a cash dividend of $2.26 per share. This strong move by Grainger underscores its commitment to providing long-term value to its shareholders. Details of the Dividend...

Continue Reading
Grupo Aeroportuario del Pacífico Secures New Credit Line Deal

Updated Category News Views 236

Grupo Aeroportuario del Pacífico Unveils Expanded Credit Line Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (PAC), a prominent player in the Mexican aviation sector, has recently announced a significant refinancing of its credit arrangements. The company has successfully secured a USD $40 million credit line from Banco Nacional de México, S.A. (Banamex). This...

Continue Reading